Pure Global

PROTEUS OX2 ANTIGEN FOR WEIL-FELIX TEST - India CDSCO Medical Device Registration

PROTEUS OX2 ANTIGEN FOR WEIL-FELIX TEST is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000044_ee20af584f8d0a2faefad41727b3246a_a4e96f502d9a758b3d32a596bdfb8860. This device is marketed under the brand name TULIP'S FEBRILE ANTIGEN SET. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is Goa.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
PROTEUS OX2 ANTIGEN FOR WEIL-FELIX TEST
UID: MFG/IVD/2019/000044_ee20af584f8d0a2faefad41727b3246a_a4e96f502d9a758b3d32a596bdfb8860

Brand Name

TULIP'S FEBRILE ANTIGEN SET

Device Class

Class B

Approving Authority

Goa

Product Information

PROGEN antigen suspensions employed in the Weil-Felix test, are used for the diagnosis of Rickettsial infection and differential diagnosis in patients with Febrile fever

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing